 Bank of New York Mellon Corp raised its stake in shares of Marinus Pharmaceuticals Inc NASDAQ:MRNS by 82.5 in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission SEC. The fund owned 237,907 shares of the biopharmaceutical companys stock after acquiring an additional 107,517 shares during ... 